Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
Moro C, Galitzky J, Sengenes C, Crampes F, Lafontan M, Berlan M. Moro C, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):984-92. doi: 10.1124/jpet.103.060913. Epub 2003 Nov 21. J Pharmacol Exp Ther. 2004. PMID: 14634036
Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.
Moro C, Pillard F, de Glisezinski I, Klimcakova E, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M. Moro C, et al. Among authors: crampes f. Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E505-13. doi: 10.1152/ajpendo.90227.2008. Epub 2008 Jun 17. Am J Physiol Endocrinol Metab. 2008. PMID: 18559985 Free article. Clinical Trial.
Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity.
Moro C, Pillard F, de Glisezinski I, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M. Moro C, et al. Among authors: crampes f. Obesity (Silver Spring). 2007 Sep;15(9):2245-55. doi: 10.1038/oby.2007.267. Obesity (Silver Spring). 2007. PMID: 17890493 Free article. Clinical Trial.
Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue.
Polak J, Moro C, Bessière D, Hejnova J, Marquès MA, Bajzova M, Lafontan M, Crampes F, Berlan M, Stich V. Polak J, et al. J Lipid Res. 2007 Oct;48(10):2236-46. doi: 10.1194/jlr.M700253-JLR200. Epub 2007 Jul 11. J Lipid Res. 2007. PMID: 17625217
Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans.
Moro C, Pillard F, de Glisezinski I, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M. Moro C, et al. Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R612-7. doi: 10.1152/ajpregu.00162.2007. Epub 2007 Jun 6. Am J Physiol Regul Integr Comp Physiol. 2007. PMID: 17553844
Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise.
Moro C, Polak J, Hejnova J, Klimcakova E, Crampes F, Stich V, Lafontan M, Berlan M. Moro C, et al. Am J Physiol Endocrinol Metab. 2006 May;290(5):E864-9. doi: 10.1152/ajpendo.00348.2005. Epub 2005 Nov 15. Am J Physiol Endocrinol Metab. 2006. PMID: 16291573 Clinical Trial.
Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men.
Moro C, Pillard F, De Glisezinski I, Harant I, Rivière D, Stich V, Lafontan M, Crampes F, Berlan M. Moro C, et al. Med Sci Sports Exerc. 2005 Jul;37(7):1126-32. doi: 10.1249/01.mss.0000170124.51659.52. Med Sci Sports Exerc. 2005. PMID: 16015128
Control of lipolysis by natriuretic peptides and cyclic GMP.
Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J. Lafontan M, et al. Among authors: crampes f. Trends Endocrinol Metab. 2008 May-Jun;19(4):130-7. doi: 10.1016/j.tem.2007.11.006. Epub 2008 Mar 11. Trends Endocrinol Metab. 2008. PMID: 18337116 Review.
An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. Lafontan M, et al. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2032-42. doi: 10.1161/01.ATV.0000183728.14712.d8. Epub 2005 Aug 25. Arterioscler Thromb Vasc Biol. 2005. PMID: 16123323 Review.
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, Lafontan M, Berlan M. Moro C, et al. FASEB J. 2004 May;18(7):908-10. doi: 10.1096/fj.03-1086fje. Epub 2004 Mar 19. FASEB J. 2004. PMID: 15033935 Clinical Trial.
51 results
Jump to page
Feedback